Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference
2019年12月18日 - 11:22PM
Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest
independent provider of home and alternate site infusion therapy
services, will present at the 38th Annual J.P. Morgan Healthcare
Conference on Monday, January 13, 2020. John C. Rademacher, Option
Care Health’s President & Chief Executive Officer is scheduled
to present at 4:30 p.m. PT. A live audio webcast and replay of this
presentation will be available at
https://investors.optioncarehealth.com.
About Option Care Health
Option Care Health, Inc. (Option Care Health) (NASDAQ: BIOS), is
the nation’s largest independent provider of home and alternate
site infusion services. With over 6,000 teammates including
2,900 clinicians, we work compassionately to elevate standards of
care for patients with acute and chronic conditions in all 50
states. Through our clinical leadership, expertise and
national scale, Option Care Health is reimagining the infusion care
experience for patients, customers and employees. To learn more,
please visit our website at OptionCareHealth.com.
For Investor Inquiries: Bob East, Asher
Dewhurst, Jordan Kohnstam Westwicke 443-213-0500
optioncarehealth@westwicke.com
For Media Inquiries: Jonathan Durrbeck
312-558-1770 JDurrbeck@pcipr.com
BioPlus Acquisition (NASDAQ:BIOS)
過去 株価チャート
から 12 2024 まで 1 2025
BioPlus Acquisition (NASDAQ:BIOS)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about BioPlus Acquisition Corporation (ナスダック市場): 0 recent articles
その他のニュース記事